Tumoral calcinosis

Tumoral calcinosis
Hand radiograph showing tumoral calcinosis, PA radiograph of the right hand showing tumoral calcinosis-like metastatic calcification in a patient on dialysis. Dialysis alters calcium phosphate product (>70). Idiopathic tumoral calcinosis is autosomal dominant and is not associated with dialysis. Note the premature arterial calcification which is a clue that this is a renal patient. Vascular calcification contributes to an increase in morbidity.
SpecialtyDermatology

Tumoral calcinosis is a skin condition where there are calcium deposits in the skin overlying joints typically in healthy black people.[1]

It is a rare condition in which there is calcium deposition in the soft tissue in periarticular location, around joints, outside the joint capsule.[2] They are frequently (0.5–3%) seen in patients undergoing renal dialysis.

The name indicates calcinosis (calcium deposition) which resembles tumor (like a new growth). They are not true neoplasms – they don't have dividing cells. They are just deposition of inorganic calcium with serum exudate.

Signs and symptoms

The symptom that the accumulations cause is not pain but swelling around joints. They have propensity to enlarge progressively and ulcerate the overlying skin and extrude. They are most common around shoulders, hips and elbows.

Cause

Clinically also known as hyperphosphatemic familial tumoral calcinosis (HFTC), is often caused by genetic mutations in genes that regulate phosphate physiology in the body (leading to too much phosphate (hyperphosphatemia)). Best described genes that harbour mutations in humans are FGF-23,[3] Klotho (KL),[4] or GALNT3.[5] A zebrafish animal model with reduced GALNT3 expression also showed HFTC-like phenotype,[6] indicating an evolutionary conserved mechanism that is involved in developing tumoral calcinosis.

Diagnosis

Laboratory evaluation reveal normal serum calcium levels and hyperphosphatemia. Rarely ALP (alkaline phosphatase – an enzyme active at sites of bone formation) may be elevated.

  • Individual with tumoral calcinosis- Lateral radiograph of the left knee demonstrating an intramedullary rod
    Individual with tumoral calcinosis- Lateral radiograph of the left knee demonstrating an intramedullary rod
  • Oblique radiograph of the right hand demonstrating soft tissue calcification, characteristic of dialysis related metastatic calcification.
    Oblique radiograph of the right hand demonstrating soft tissue calcification, characteristic of dialysis related metastatic calcification.
  • tumorous calcinosis over a malleolus in ultrasound
    tumorous calcinosis over a malleolus in ultrasound

Management

Treatment is normalization of serum phosphate levels and resection of lesions. Surgical removal should be complete and if part of it is left, recurrence is likely to occur. Cutting through the excised calcium deposition reveals semifluid calcium suspension in albumin encapsulated by fibrous tissue.

Epidemiology

Children and adolescents (6 to 25 years) are the most commonly affected.

References

  1. ↑ Johnstone, Ronald B. (2017). "14. Cutaneous deposits". Weedon's Skin Pathology Essentials (2nd ed.). Elsevier. p. 280. ISBN 978-0-7020-6830-0. Archived from the original on 2021-05-25. Retrieved 2022-09-27.
  2. ↑ "Orthobullets". Archived from the original on 27 October 2014. Retrieved 27 October 2014.
  3. ↑ Araya, Kaori; Fukumoto, Seiji; Backenroth, Rebecca; Takeuchi, Yasuhiro; Nakayama, Kounosuke; Ito, Nobuaki; Yoshii, Nozomi; Yamazaki, Yuji; Yamashita, Takeyoshi; Silver, Justin; Igarashi, Takashi (2005-10-01). "A Novel Mutation in Fibroblast Growth Factor 23 Gene as a Cause of Tumoral Calcinosis". The Journal of Clinical Endocrinology & Metabolism. 90 (10): 5523–5527. doi:10.1210/jc.2005-0301. ISSN 0021-972X. Archived from the original on 2018-06-02. Retrieved 2022-01-21.
  4. ↑ Ichikawa, Shoji; Imel, Erik A.; Kreiter, Mary L.; Yu, Xijie; Mackenzie, Donald S.; Sorenson, Andrea H.; Goetz, Regina; Mohammadi, Moosa; White, Kenneth E.; Econs, Michael J. (2007-09-04). "A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis". Journal of Clinical Investigation. 117 (9): 2684–2691. doi:10.1172/JCI31330. ISSN 0021-9738. PMC 1940239. PMID 17710231.
  5. ↑ Topaz, Orit; Shurman, Daniel L; Bergman, Reuven; Indelman, Margarita; Ratajczak, Paulina; Mizrachi, Mordechai; Khamaysi, Ziad; Behar, Doron; Petronius, Dan; Friedman, Vered; Zelikovic, Israel (June 2004). "Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis". Nature Genetics. 36 (6): 579–581. doi:10.1038/ng1358. ISSN 1061-4036. Archived from the original on 2022-01-21. Retrieved 2022-01-21.
  6. ↑ Stevenson, Nicola L.; Bergen, Dylan J. M.; Skinner, Roderick E. H.; Kague, Erika; Martin-Silverstone, Elizabeth; Robson Brown, Kate A.; Hammond, Chrissy L.; Stephens, David J. (2017-12-15). "Giantin-knockout models reveal a feedback loop between Golgi function and glycosyltransferase expression". Journal of Cell Science. 130 (24): 4132–4143. doi:10.1242/jcs.212308. ISSN 0021-9533. PMC 5769581. PMID 29093022. Archived from the original on 2022-03-19. Retrieved 2022-01-21.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.